Research location

Shatin, NT

Hong Kong

Published trials6
Site observations6
Linked trials published5
Page1 / 1
Advertisement

Research activity in Shatin, NT

Hong Kong

CureCurrent currently publishes aggregate city-level research activity for this location: 6 trials and 6 site observations.

The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.

Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.

Trials with sites in Shatin, NT

5 linked trials · page 1 of 1
A Study to Investigate Long-term Safety and Tolerability of Tolebrutinib in Participants With Multiple Sclerosis.NCT06372145 · 2024-04-16 · 1 site observation
ACTIVE_NOT_RECRUITING
Relapsing Forms of Multiple Sclerosis (RMS) Study of Bruton's Tyrosine Kinase (BTK) Inhibitor Tolebrutinib (SAR442168) (GEMINI 1)NCT04410978 · 2020-06-30 · 1 site observation
COMPLETED
Dacomitinib (PF-00299804) As A Single Oral Agent In Selected Patients With Adenocarcinoma Of The LungNCT00818441 · 2009-03-11 · 1 site observation
COMPLETED
A Study In Patients With Non-Small Cell Lung Cancer To Test If Erlotinib Plus SU011248 Is Better Than Erlotinib AloneNCT00457392 · 2007-07-01 · 1 site observation
COMPLETED
Olmesartan Alone or in Combination With Hydrochlorothiazide in Subjects With Mild to Moderate Essential HypertensionNCT00139698 · 2005-09-01 · 1 site observation
COMPLETED

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.